79 patients with suspected myocardial infarction entered a randomised trial to establish the safety of early intravenous administration of a highly purified hyaluronidase preparation ( gl enzyme ) and to assess its effects on eventual infarct size as measured by electrocardiographic , enzymatic , and scintigraphic criteria .
C0027051
myocardial infarction
C0021308
infarct